PriceTargets.com logo

Molina Healthcare - MOH Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $365.38
  • Forecasted Upside: 17.68%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 9 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$310.48 As of 05/13/2025 05:00 PM ET
▼ -17.21 (-5.25%)

This chart shows the closing price for MOH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
MarAprMay$327.47Closing price on 05/12/25:
Get New Molina Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MOH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MOH

Analyst Price Target is $365.38
▲ +17.68% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Molina Healthcare in the last 3 months. The average price target is $365.38, with a high forecast of $414.00 and a low forecast of $297.00. The average price target represents a 17.68% upside from the last price of $310.48.

This chart shows the closing price for MOH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
5/248/2411/242/255/255/26$187$243$300$357$414Closing price on 05/12/25: $327.47High$414.00Average$365.38Low$297.00




Current Consensus is Hold

The current consensus among 15 contributing investment analysts is to hold stock in Molina Healthcare. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/18/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
5/18/2024
  • 1 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
8/16/2024
  • 1 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
11/14/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
2/12/2025
  • 1 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
4/13/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2025

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/25/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$339.00 ➝ $362.00
4/22/2025Sanford C. BernsteinInitiated CoverageOutperform$414.00
4/15/2025Baird R WDowngradeStrong-Buy ➝ Hold
4/15/2025Robert W. BairdReiterated RatingOutperform ➝ Neutral$331.00 ➝ $375.00
4/11/2025Truist FinancialBoost TargetBuy ➝ Buy$340.00 ➝ $400.00
4/9/2025GuggenheimInitiated CoverageNeutral
4/9/2025MizuhoBoost TargetOutperform ➝ Outperform$376.00 ➝ $400.00
3/5/2025Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$295.00 ➝ $372.00
3/3/2025MizuhoLower TargetOutperform ➝ Outperform$382.00 ➝ $376.00
2/19/2025Truist FinancialLower TargetBuy ➝ Buy$370.00 ➝ $340.00
2/7/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$372.00 ➝ $339.00
2/7/2025UBS GroupLower TargetNeutral ➝ Neutral$374.00 ➝ $325.00
2/6/2025StephensReiterated RatingEqual Weight ➝ Equal Weight$345.00 ➝ $345.00
1/6/2025Truist FinancialLower TargetBuy ➝ Buy$400.00 ➝ $370.00
12/17/2024JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$378.00 ➝ $350.00
11/4/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$360.00 ➝ $362.00
10/25/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$359.00 ➝ $372.00
10/24/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$406.00 ➝ $406.00
10/24/2024Robert W. BairdLower TargetOutperform ➝ Outperform$405.00 ➝ $331.00
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$406.00 ➝ $406.00
9/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$406.00 ➝ $406.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$406.00 ➝ $406.00
8/5/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$315.00 ➝ $360.00
7/29/2024Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$354.00 ➝ $353.00
7/25/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$320.00 ➝ $320.00
7/24/2024Jefferies Financial GroupLower TargetHold ➝ Hold$354.00 ➝ $297.00
7/24/2024TD CowenLower TargetBuy ➝ Buy$412.00 ➝ $351.00
7/23/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$406.00 ➝ $406.00
7/22/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$375.00 ➝ $315.00
7/15/2024Truist FinancialLower TargetBuy ➝ Buy$440.00 ➝ $400.00
7/10/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$420.00 ➝ $395.00
5/30/2024Baird R WUpgradeStrong-Buy
5/30/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$435.00 ➝ $420.00
5/30/2024Robert W. BairdInitiated CoverageOutperform$405.00
4/30/2024TD CowenLower TargetBuy ➝ Buy$453.00 ➝ $412.00
4/29/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$410.00 ➝ $375.00
4/25/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$437.00 ➝ $430.00
4/25/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$390.00
4/15/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$440.00 ➝ $410.00
4/4/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$406.00
3/28/2024Bank of AmericaDowngradeNeutral ➝ Underperform$439.00
3/20/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$420.00 ➝ $440.00
3/6/2024BarclaysInitiated CoverageEqual Weight$437.00
2/20/2024Truist FinancialBoost TargetBuy ➝ Buy$435.00 ➝ $460.00
2/15/2024Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$367.00 ➝ $420.00
2/9/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$374.00 ➝ $406.00
12/21/2023UBS GroupBoost TargetNeutral ➝ Neutral$350.00 ➝ $380.00
11/21/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$374.00
11/17/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$367.00 ➝ $392.00
10/3/2023StephensReiterated RatingEqual Weight ➝ Equal Weight$350.00
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$359.00
7/27/2023Bank of AmericaBoost Target$340.00 ➝ $350.00
7/14/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$365.00
7/7/2023JPMorgan Chase & Co.Lower Target$348.00 ➝ $341.00
6/20/2023Truist FinancialLower Target$380.00 ➝ $365.00
6/20/2023UBS GroupInitiated CoverageNeutral$310.00
5/8/2023Deutsche Bank AktiengesellschaftLower Target$365.00 ➝ $335.00
5/1/2023Deutsche Bank AktiengesellschaftBoost Target$356.00 ➝ $365.00
4/28/2023Credit Suisse GroupBoost Target$347.00 ➝ $350.00
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$354.00
3/21/2023Wells Fargo & CompanyLower TargetUnderweight$307.00 ➝ $282.00
2/23/2023JPMorgan Chase & Co.Lower TargetOverweight$360.00 ➝ $348.00
2/17/2023Wells Fargo & CompanyLower TargetUnderweight$340.00 ➝ $307.00
2/10/2023Credit Suisse GroupLower TargetOutperform$395.00 ➝ $347.00
2/10/2023Truist FinancialLower TargetBuy$400.00 ➝ $380.00
2/9/2023StephensReiterated RatingEqual Weight$375.00
1/4/2023BarclaysLower TargetOverweight$400.00 ➝ $375.00
1/3/2023Wells Fargo & CompanyLower TargetUnderweight$345.00 ➝ $340.00
12/13/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$388.00
11/7/2022CowenBoost Target$371.00 ➝ $380.00
11/7/2022CowenBoost Target$371.00 ➝ $380.00
11/1/2022Deutsche Bank AktiengesellschaftBoost TargetHold$315.00 ➝ $355.00
10/28/2022BarclaysBoost TargetOverweight$380.00 ➝ $400.00
10/28/2022Truist FinancialBoost TargetBuy$390.00 ➝ $420.00
10/27/2022Credit Suisse GroupBoost TargetOutperform$350.00 ➝ $410.00
10/3/2022JPMorgan Chase & Co.Initiated CoverageOverweight$360.00
8/26/2022Wells Fargo & CompanyBoost TargetUnderweight$307.00 ➝ $345.00
8/9/2022CowenBoost Target$371.00
8/1/2022Deutsche Bank AktiengesellschaftBoost Target$311.00 ➝ $315.00
7/19/2022Credit Suisse GroupSet Target$321.00
6/16/2022Loop CapitalInitiated CoverageHold$310.00
5/26/2022Bank of AmericaDowngradeBuy ➝ Underperform$355.00 ➝ $335.00
5/25/2022Wells Fargo & CompanyLower TargetUnderweight$308.00 ➝ $301.00
5/2/2022CowenBoost Target$356.00 ➝ $366.00
5/2/2022CowenBoost Target$356.00 ➝ $366.00
5/2/2022Deutsche Bank AktiengesellschaftBoost Target$308.00 ➝ $311.00
4/7/2022Truist FinancialBoost Target$360.00 ➝ $390.00
2/22/2022Morgan StanleyLower TargetOverweight$397.00 ➝ $365.00
2/14/2022BMO Capital MarketsBoost TargetOutperform$365.00 ➝ $380.00
2/11/2022Deutsche Bank AktiengesellschaftBoost Target$304.00 ➝ $308.00
2/11/2022MizuhoBoost TargetBuy$330.00 ➝ $345.00
1/5/2022Truist FinancialBoost Target$345.00 ➝ $360.00
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$335.00
11/22/2021Deutsche Bank AktiengesellschaftInitiated CoverageHold
11/2/2021Wells Fargo & CompanyBoost TargetUnderweight$256.00 ➝ $281.00
11/1/2021MizuhoBoost TargetBuy$305.00 ➝ $330.00
10/29/2021Morgan StanleyBoost TargetOverweight$316.00 ➝ $397.00
10/29/2021StephensBoost TargetEqual Weight$280.00 ➝ $300.00
10/29/2021Credit Suisse GroupBoost TargetOutperform$318.00 ➝ $330.00
10/29/2021BarclaysBoost TargetOverweight$310.00 ➝ $340.00
9/20/2021Morgan StanleyBoost TargetOverweight$296.00 ➝ $316.00
9/20/2021Truist FinancialBoost TargetBuy$300.00 ➝ $330.00
9/20/2021Credit Suisse GroupBoost TargetOutperform$280.00 ➝ $318.00
9/20/2021StephensBoost TargetEqual Weight$260.00 ➝ $280.00
9/20/2021MizuhoBoost TargetBuy$284.00 ➝ $305.00
9/9/2021CowenInitiated CoverageOutperform$336.00
8/31/2021Morgan StanleyLower TargetOverweight$297.00 ➝ $296.00
8/3/2021Wells Fargo & CompanyBoost TargetUnderweight$253.00 ➝ $256.00
7/30/2021BMO Capital MarketsBoost TargetOutperform$300.00 ➝ $315.00
7/30/2021MizuhoBoost TargetBuy$273.00 ➝ $284.00
7/9/2021Seaport Res PtnReiterated RatingNeutral
6/3/2021Morgan StanleyBoost TargetOverweight$244.00 ➝ $297.00
5/24/2021Wells Fargo & CompanyInitiated CoverageUnderweight$253.00
5/18/2021Wells Fargo & CompanyInitiated CoverageUnderweight$253.00
4/30/2021MizuhoBoost TargetBuy$245.00 ➝ $273.00
4/14/2021Truist FinancialBoost TargetBuy$260.00 ➝ $290.00
3/30/2021Credit Suisse GroupInitiated CoverageOutperform$260.00
3/15/2021MizuhoInitiated CoverageBuy$245.00
3/9/2021MizuhoInitiated CoverageBuy$245.00
2/19/2021BarclaysReiterated RatingOverweight$260.00
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutral$217.00
1/5/2021Truist FinancialBoost Target$240.00 ➝ $260.00
11/11/2020Piper SandlerBoost TargetOverweight$213.00 ➝ $266.00
10/30/2020Leerink PartnersBoost TargetOutperform$228.00 ➝ $255.00
9/22/2020StephensDowngradeOverweight ➝ Equal Weight
9/1/2020Leerink PartnersBoost TargetOutperform$226.00 ➝ $228.00
8/3/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$188.00 ➝ $194.00
8/3/2020Leerink PartnersBoost TargetOutperform$220.00 ➝ $226.00
7/1/2020Leerink PartnersInitiated CoverageOutperform$220.00
6/16/2020CowenUpgradeMarket Perform ➝ Outperform$200.00 ➝ $210.00
6/1/2020SunTrust BanksBoost TargetPositive ➝ Buy$210.00 ➝ $230.00
6/1/2020StephensBoost TargetOverweight$202.00 ➝ $215.00
5/15/2020Morgan StanleyBoost TargetOverweight$175.00 ➝ $229.00
(Data available from 5/13/2020 forward)

News Sentiment Rating

1.28 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 19 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
10/15/2024
  • 27 very positive mentions
  • 23 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
11/14/2024
  • 49 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
12/14/2024
  • 11 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
1/13/2025
  • 44 very positive mentions
  • 30 positive mentions
  • 10 negative mentions
  • 1 very negative mentions
Mentions as of
2/12/2025
  • 41 very positive mentions
  • 19 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
Mentions as of
3/14/2025
  • 70 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
4/13/2025
  • 77 very positive mentions
  • 29 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/13/2025

Current Sentiment

  • 77 very positive mentions
  • 29 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Molina Healthcare logo
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Today's Range

Now: $310.48
Low: $307.48
High: $322.03

50 Day Range

MA: $325.04
Low: $301.66
High: $353.48

52 Week Range

Now: $310.48
Low: $262.32
High: $365.23

Volume

744,915 shs

Average Volume

682,427 shs

Market Capitalization

$16.83 billion

P/E Ratio

15.20

Dividend Yield

N/A

Beta

0.63

Frequently Asked Questions

What sell-side analysts currently cover shares of Molina Healthcare?

The following Wall Street research analysts have issued research reports on Molina Healthcare in the last year: Baird R W, Barclays PLC, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Robert W. Baird, Sanford C. Bernstein, Stephens, StockNews.com, TD Cowen, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for MOH.

What is the current price target for Molina Healthcare?

0 Wall Street analysts have set twelve-month price targets for Molina Healthcare in the last year. Their average twelve-month price target is $365.38, suggesting a possible upside of 17.7%. Sanford C. Bernstein has the highest price target set, predicting MOH will reach $414.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $297.00 for Molina Healthcare in the next year.
View the latest price targets for MOH.

What is the current consensus analyst rating for Molina Healthcare?

Molina Healthcare currently has 9 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MOH, but not buy more shares or sell existing shares.
View the latest ratings for MOH.

What other companies compete with Molina Healthcare?

Other companies that are similar to Molina Healthcare include Centene, Humana, UnitedHealth Group, Elevance Health and The Cigna Group. Learn More about companies similar to Molina Healthcare.

How do I contact Molina Healthcare's investor relations team?

Molina Healthcare's physical mailing address is 200 OCEANGATE SUITE 100, LONG BEACH CA, 90802. The company's listed phone number is (562) 435-3666 and its investor relations email address is julie.trudell@molinahealthcare.com. The official website for Molina Healthcare is www.molinahealthcare.com. Learn More about contacing Molina Healthcare investor relations.